CapsoVision (CV) Depreciation & Amortization (CF) (2024 - 2025)

CapsoVision (CV) reported Depreciation & Amortization (CF) of $55000.0 for Q4 2025, up 7.84% on a YoY basis from $51000.0 in Q4 2024, and up 1.85% sequentially from $54000.0 in Q3 2025.

CapsoVision (CV) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

CapsoVision (CV) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $55000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 7.84% year-over-year to $55000.0; the trailing twelve-month figure through Dec 2025 stood at $215000.0 (changed N/A YoY), and the FY2025 full-year result was $216000.0, up 4.85% from the prior year.
  • Depreciation & Amortization (CF) rose to $55000.0 in Q4 2025, from $54000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $55000.0 in Q2 2025 to a low of $51000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CapsoVision 162.07 Mn 151.95 Mn 1.95 Mn 55,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 55,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 54,000.00
Sep 30, 2025 54,000.00
Jun 30, 2025 55,000.00
Jun 30, 2025 55,000.00
Dec 31, 2024 51,000.00
Dec 31, 2024 51,000.00
Sep 30, 2024 52,000.00
Sep 30, 2024 52,000.00
Jun 30, 2024 52,000.00
Jun 30, 2024 52,000.00